Frankfurt - Delayed Quote EUR
Sangamo Therapeutics, Inc. (GBY.F)
0.3775
+0.0290
+(8.32%)
At close: May 16 at 9:39:12 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 29.9M | 5.83M | 48.74M | 42.57M |
| Low Estimate | 400k | -- | 20.8M | 9.9M |
| High Estimate | 100M | 13M | 106.4M | 114.2M |
| Year Ago Sales | 356k | 49.41M | 57.8M | 48.74M |
| Sales Growth (year/est) | 8,298.88% | -88.19% | -15.67% | -12.65% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GBY.F | -- | -- | -- | -- |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 5/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/7/2025 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 3/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/27/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/2/2025 |
Related Tickers
BVNKF Bavarian Nordic A/S
26.80
0.00%
BVNRY Bavarian Nordic A/S
8.24
+1.35%
HOOK HOOKIPA Pharma Inc.
1.5600
+7.59%
PLRX Pliant Therapeutics, Inc.
1.3800
+0.73%
TRAW Traws Pharma, Inc.
1.1900
+6.25%
ASMB Assembly Biosciences, Inc.
13.42
+7.36%
PALI Palisade Bio, Inc.
0.6868
+0.99%
SYRS Syros Pharmaceuticals, Inc.
0.0335
+7.03%
SPRC SciSparc Ltd.
0.3159
+3.24%
VRPX Virpax Pharmaceuticals, Inc.
0.2200
-12.00%